<?xml version="1.0" encoding="UTF-8"?>
<results title="migration">
 <result pre="Conversely, these compounds were not able to counteract the spontaneous" exact="migration" post="of human cancer HCT116 cell line in the wound"/>
 <result pre="compound treatment and, lastly, the capability to limit the spontaneous" exact="migration" post="of HCT116 cells in the wound healing paradigm. 2."/>
 <result pre="of the most potent compounds were evaluated on the spontaneous" exact="migration" post="of HCT116 cells, in the 48 h following the experimental"/>
 <result pre="studied in order to evaluate their effects on the spontaneous" exact="migration" post="of HCT116 cells, through the wound healing paradigm. In"/>
 <result pre="VIe and VIk at their respective IC50 values. The spontaneous" exact="migration" post="of HCT116 cells was monitored in the 48 h following"/>
 <result pre="experimental lesion of cell monolayer. The null effects on sponstaneous" exact="migration" post="(Figure 6) rule out any involvement of the tested"/>
 <result pre="of compounds VIe (3.09 µg/mL) and VIk (2.73 µg/mL) on the spontaneous" exact="migration" post="of human colon cancer HCT116 cell line (wound healing"/>
 <result pre="colon cancer HCT116 cell line (wound healing paradigm). The spontaneous" exact="migration" post="was monitored in the 48 h following treatment. Data are"/>
 <result pre="a standard drug at basal conditions. Disclosure statement No potential" exact="conflict" post="of interest was reported by the author(s). References References"/>
 <result pre="(Amst)2018;2018:1–11. 31WalczakK, Deneka-HannemannS, JaroszB, et al.Kynurenic acid inhibits proliferation and" exact="migration" post="of human glioblastoma T98G cells. Pharmacol Rep2014;66:130–6.24905318 32WalczakK, TurskiWA,"/>
</results>
